Login / Signup

Sofosbuvir plus velpatasvir combination for the treatment of chronic hepatitis C in patients with end stage renal disease on renal replacement therapy: A systematic review and meta-analysis.

Arka DeAkash RoyNipun VermaSaurabh MishraMadhumita PremkumarSunil TanejaVirendra SinghAjay Kumar Duseja
Published in: Nephrology (Carlton, Vic.) (2021)
The fixed-dose combination of SOF and VEL is effective and safe in CHC patients with ESRD on RRT.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • peritoneal dialysis
  • hepatitis c virus
  • acute kidney injury
  • liver fibrosis